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Abstract
Background/Aim. Peri-implantitis presents inflammatory
process that affects soft and hard supporting tissues of os-
seointegrated implant based on inflammatory osteoclasto-
genesis. The aim of this study was to investigate whether re-
ceptor activator of nuclear factor kappa B (RANK) con-
centrations in peri-implant crevicular fluid could be associ-
ated with clinical parameters that reflect inflammatory na-
ture of peri-implantitis. Methods. The study included 67
patients, 22 with diagnosed peri-implantitis, 22 persons with
healthy peri-implant tissues and 23 patients with periodon-
titis. Clinical parameters from each patient were recorded
and samples of peri-implant/gingival crevicular fluid were
collected for the enzyme-linked immunosorbent assay
(ELISA) analysis. Results. RANK concentration was sig-
nificantly increased in samples from the patients with peri-
implantitis when compared to healthy implants (p < 0.0001),
where the average levels were 9 times higher. At the same
time RANK concentration was significantly higher in peri-
implantitis than in periodontitis sites (p < 0.0001). In im-
plant patients pocket depths and bleeding on probing values
were positively associated with high RANK concentrations
(p < 0.0001). Conclusion. These results revealed associa-
tion of increased RANK concentration in samples of peri-
implant/gingival crevicular fluid with peri-implant inflam-
mation and suggests that RANK could be a pathologic de-
terminant of peri-implantitis, thereby a potential parameter
in assessment of peri-implant tissue inflammation and a
potential target in designing treatment strategies.
Key words:
receptor activator of nuclear factor-kappa b; sensitivity
and specificity; dental implantation, endosseus;
periodontitis.
Apstrakt
Uvod/Cilj. Periimplantitis predstavlja inflamatorni proces
koji zahvata meko i tvrdo potporno tkivo osteointegrisa-
nog implantata, i zasnovan je na inflamatornoj osteoklas-
togenezi. Cilj studije bio je da se utvrdi povezanost kon-
centracije receptora aktivatora nuklearnog faktora kapa-B
(RANK), kao glavnog receptora osteoklastnog metaboliz-
ma, sa kliniÿkim parametrima periimplantitisa. Metode.
Studija je ukljuÿila 67 sistemski zdravih pacijenata (22 sa
periimplantitisom, 22 sa zdravim implantatima i 23 sa pe-
riodontopatijom). Pacijentima su mereni kliniÿki parametri
i uziman je uzorak periimplantne/gingivalne teÿnosti za
odreĀivanje koncentracije RANK-a ELISA metodom. Re-
zultati. Koncentracija RANK-a bila je znaÿajno povišena
kod periimplantitisa u odnosu na zdrave implantate (p <
0,0001), gde je srednja vrednost koncentracije bila 9 puta
veýa. Istovremeno, RANK je bio znaÿajno viši kod peri-
implantitisa nego kod parodontopatije (p < 0,0001). U
grupi sa implantatima dubina periodontalnog džepa i krva-
renje na probu bili su pozitivno udruženi sa visokim vred-
nostima RANK-a (p < 0,0001). Zakljuÿak. Rezultati istra-
živanja pokazuju udruženost povišenosti koncentracije
RANK-a sa periimplantnom inflamacijom i navodi na za-
kljuÿak da bi RANK mogao da bude patološka determi-
nanta periimplantitisa, a time i potencijalni parametar za
praýenje inflamacije periimplantnog tkiva i potencijalni cilj
za pravljenje terapijskih strategija.
Kljuÿne reÿi:
receptor, aktivator nuklearnog faktora-kappa-b;
osetljivost i specifiÿnost; stomatološka enosalna
implantacija; periodontitis.Volumen 70, Broj 4 VOJNOSANITETSKI PREGLED Strana 347
Rakiý M, et al. Vojnosanit Pregl 2013; 70(4): 346–351.
Introduction
Peri-implantitis represents an inflammatory process that
affects soft and hard supporting tissues of an osseointegrated
implant, where the infection and excessive biomechanical
forces are recognized as main etiologic factors 
1, 2. After in-
duction, the peri-implantitis pathogenesis results from the
interplay between specific subgingival microorganisms and
inflammatory and immune responses, acting in the same way
and using the same effector mechanisms as evidenced in
periodontal disease (periodontitis) 
3, 4. Aggregatibacter acti-
nomycetemcomitans, a gram-negative facultative capnophilic
bacteria, is identified as the major etiological pathogen of lo-
calized juvenile periodontitis (LJP) until recently known as
localized aggressive periodontitis and rapidly progressing
periodontitis 
5. Data from experimental model of (NOD)-
SCID mice reconstituted with human peripheral blood leu-
kocytes from patients with periodontitis and challenged with
A. actinomycetemcomitans clearly showed that activated
human CD4 T cells are essential effectors of alveolar bone
destruction 
6. Maintenance, formation, and remodeling of al-
veolar bone is an outcome of balanced activity of final ef-
fector cells, bone-resorbing osteoclasts and bone-producing
osteoblasts. Osteoclastogenesis with consequential bone loss
represents the hallmark of peri-implantitis, distinguishing it
from previous developmental stage, peri-mucositis, where
the process is limited only on soft tissues 
7, 8. In course of
such inflammatory bone resorption, receptor activator of nu-
clear factor kappa B (RANK) and his ligand (RANKL) have
been recognized as key regulatory factors in osteoclasts me-
tabolism 
9–11, particularly in periodontal disease. Receptor
activator of nuclear factor kappa B also known as the osteo-
clasts differentiation factor receptor is a 11A member of the
tumor necrosis factor (TNF) superfamily. The human RANK
is a transmembrane receptor of 616 amino-acids expressed
primarily on the cells of the monocyte/macrophage lineage
including preosteoclasts and osteoclasts, B- and T- lympho-
cytes, dendritic cells and fibroblasts 
12, 13. Since RANK is lo-
calized on the surfaces of preosteoclasts and osteoclasts its
ligation by a specific ligand, RANKL, leads to differentiation
and maturation of progenitor cells simultaneously with os-
teoclasts activity enhancement 
14–16. The key signal for this
mechanism is the achievement of critical concentrations of
pro-inflammatory cytokines whose gene transcription is
regulated by  nuclear factor kappa B (NF-țB) 
17.
Regulation of RANK/RANKL interaction is performed
by a receptor-like molecule named osteoprotegerin (OPG)
which binds RANKL with high affinity and thereby blocks
RANKL/RANK interaction with a consequential inhibition
of osteoclasts activity 
18, 19. RANKL could be found in solu-
ble form or expressed by osteoblasts, stromal cells, fibro-
blasts, B-cells and T-cells 
20, 17 under different stimulation
such as pro-resorptive hormones (such as parathormone, epi-
nephrine, 17ȕ-estradiol and glucocorticoides), cytokines
(such as IL-1, IL-6, IL-8, IL-11, IL-17, TNFĮ and IFNȖ)  and
bacterial lipopolysaccharide (LPS) 
18, 21.
Clinical and radiological parameters of peri-implantitis
are conventional tools for determining diagnosis and status in
established tissue impairment, but are insensitive for early
diagnosis and as a prognostic factors. Peri-implant crevicular
fluid (PICF) was found to be reliable in reflecting surround-
ing tissues status since the volume and composition directly
depends on their condition 
22. Considering that, a number of
researches were conducted on the topic of RANKL and OPG
evaluation in PICF and gingival crevicular fluid (GCF) at
different statuses of supporting tissues 
23, 24. However, these
results on RANK and its role in peri-implantitis are still non-
existent. The aim of this study was to investigate whether
RANK concentrations in PICF could be associated with
clinical parameters that reflect inflammatory nature of peri-
implantitis.
Methods
This was the cross-sectional study conducted in the
Clinic of Periodontology and Oral Medicine, School of Den-
tistry, Belgrade, Serbia, Clinic for Maxillofacial, Oral Sur-
gery and Implantology, Military Medical Academy and In-
stitute for Medical Research, Military Medical Academy
from June 2009 until February 2011. The study included 67
patients divided into 3 groups: peri-implantitis (n = 22),
healthy implants (n = 22) and periodontitis (n = 23). Peri-
implantitis was accepted in the presence of clinical signs
(Figure 1) including: peri-implant pocket depth (PPD)  5
mm or in the presence of gingival recession relative clinical
attachment level (rCAL )  4 mm, with positive bleeding on
probing (BOP) and recorded radiographic bone loss involv-
ing  2 threads compared to radiography taken at the time of
prosthetic replacement. Intraoral radiographies were per-
formed for radiological evidence of bone loss using paral-
leling technique, where implant threads were used as referent
points. Only peri-implantitis after at least 2 years of loading
and without previous peri-implantitis treating were included.
As healthy peri-implant tissues were accepted implants with-
out any clinical signs of inflammation including the absence
of subjective difficulties, BOP = 0 and PPD  3mm. Implants
included in the study were delayed loaded endosseal im-
plants with the purity level of 2/ASTM (American Society
Fig. 1 – Clinical signs of peri-implantitis presented by posi-
tive bleeding on probing and a clinically visible loss of soft
and hard peri-implant tissuesStrana 348 VOJNOSANITETSKI PREGLED Volumen 70, Broj 4
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for Testing and Materials) (99.98%) and a sand-blasted,
large-grit, acid (SLA) etched surface inserted. Implants were
4.5 mm in diameter, 3.5 mm long with 4 threads. As peri-
odontitis were accepted the patients with diagnosed severe
generalized chronic periodontitis accordingly to the classifi-
cation of periodontal disease 
25.
All the patients were systemically healthy adult non-
smokers, and exclusion criteria were received peri-
implant/periodontal treatment in the preceding 1 year, usage
of antibiotics and anti-inflammatory agents within the pre-
ceding 3 months, menstruation, pregnancy and lactation in
female patients. The study protocol was approved by the
Ethics Committees of both two institutions (Ethics Commit-
tee School of Dentistry and Ethics Committee Military
Medical Academy), patients were informed on the study
protocol and they were obligated to give written consent be-
fore procedures.
Clinical examination
The following clinical parameters were measured in 6
points: mesio-bucal, medio-bucal, disto-bucal, mesio-lingual,
medio-lingual and disto-lingual (Figure 2): PPD and packet
depth (PD) by BOP:  presence (1) or absence (0) of bleeding
for up to 15 sec after probing, and visible plaque accumula-
tion (PI): presence (1) or absence (0) of plaque along the
mucosal margin 
26. All measurements were performed by the
one same trained and calibrated examiner using the same
type of the graduated periodontal probe (North Carolina–Hu-
Friedy, Chicago, IL, USA). Intra-examiner calibration was
performed twice, before and during the study, by assessing
PPD and with a degree of agreement within ± 1 mm higher
than 85%. The implant/tooth site with the deepest probing
depth was chosen as a representative for sampling; in case of
similar probing depths the anterior point was chosen as a step
toward higher precision.
Fig. 2 – Measurement of periodontal pocket depth using a
graduated periodontal probe at the tooth with positive
bleeding on probing and with a clinically visible loss of soft
and hard periodontal tissues
The peri-implant crevicular fluid (PICF) and gingival
crevicular fluid (GCF)sampling
PICP and GCF samples were obtained from the patients
using the filter paper technique 24 h after the examination.
After removing the supragingival biofilm with sterile cotton
rolls, the sampling place was isolated with cotton rolls and
gently air dried 1 min before sampling in the aim to eliminate
any potential contamination with saliva. A paper strip of stan-
dard length and height (Periopaper, Pro Flow, Amityville, NY,
USA) was inserted into the peri-implant and gingi-
val/periodontal sulcus/pocket until mild resistance was felt and
left in place for 30 s. Strips that were visually contaminated
with blood or saliva were discarded. Sampled fluid volume
was measured with calibrated Periotron 6000 (Interstate Drug
Exchange, Amityville, NY, USA). After measurement strips
were inserted in microcentrifuge plastic tubes with 100 ȝL of
sterile phosphatebuffered saline. The sampling time method
which includes a total amount of RANK in picograms (pg) per
site during 30 s was chosen because the method was supported
by previous studies as convenient for related researches 
27.
Following 10 s of vortexing, eluates were centrifuged 5 min at
3000 g to remove plaque and cellular elements, after that the
strips were removed. The samples were stored at í70°C until
enzyme-linked immunosorbent assay (ELISA) analysis.
Determination of RANK using ELISA
Concentrations of RANK in PICF and GCF were as-
sessed using a commercially available ELISA kit (R&D
Systems Inc., Minneapolis, MN, USA) according to the
manufacturer’s recommendations. A calibration curve was
plotted by regression analysis and the optical density of the
sample was used to estimate the concentration of RANK.
The intensity of the color was measured using spectropho-
tometry (450/620 nm, ELISA processor II, Boehring, Ger-
many). The obtained values of RANK were calculated from
picomoles into picograms, and the concentration was ex-
pressed as RANK (pg) per sample / PICF volume (mL).
Statistical analysis
Analysis of the obtained data was performed using sta-
tistical software (SAS Enterprise Guide 4.1, SAS Institute Inc.,
2008).  After descriptive statistical analysis, data were exam-
ined by the Shapiro-Wilk and Kolmogorov-Smirnov test in or-
der to test the normality assumption.  Since normality was not
achieved for each clinical parameter, further analysis was
based upon non-parametric tests. In some cases „Exact“ option
was applied in order to obtain more precise p values. The Wil-
coxon test was done to assess the difference in mean for each
clinical parameter within groups, whereas another pair wise
comparison was done by the Kruskal–Wallis test. The signifi-
cance level established for all analyses was 5% (p < 0.05).
Results
The study population of 67 subjects included 30 fe-
males and 37 males, the average age of 38.8 ± 7.73 years
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The volume of collected PICF/GCF was similar in
samples of all the investigated groups (Table 1). Mean score
values of PPD, BOP and plaque accumulation index (PI)
were as expected significantly elevated in the peri-implantitis
and periodontitis groups comparing to the controls, but did
not differ among each other. Finally, mean RANK levels
were highest in the samples of the peri-implantits group and
lowest in the control group. Score values of BOP, PI, PPD,
volume of collected PICF/GCF and RANK concentrations
did not correlate with gender and age of the investigated
subjects (Table 2).
The concentration of RANK was significantly higher in
the peri-implantitis than in the control group with healthy
implants (p < 0.0001). By comparing RANK concentration
between the peri-implantitis and the periodontitis group it is
observed that RANK concentration was significantly in-
creased in peri-implantitis sites (p < 0.0001) (Table 3).
The score values of all the clinical parameters were sig-
nificantly increased in inflamed sites, either in peri-implantitis
or periodontitis groups, as expected considering group’s char-
acteristics. When we divided patients with peri-implantits ac-
cording to RANK levels detected in their PICF, mean score
levels of peri-implant pocket depth and positive bleeding on
probing were significantly higher in those patients that had
RANK levels above 1,000 pg/mL, comparing to the  group of
those patient with lower RANK concentration (Table 4). These
findings point out strong association of crucial clinical signs,
PPD and BOP with high local RANK concentration.
Discussion
A variety of studies were dedicated to resolution of the
multifactorial pathogenesis of peri-implantitis, aiming to im-
prove the success of one of the main therapeutic solutions in
contemporary dentistry. Still, numerous efforts to identify any
Table 1
Descriptive statistics of RANK concentration and the measured clinical parameters among the groups
Group of patients PICF/GCF
(uL)
RANK
(pg/mL)
BOP
(score)
PI
(score)
PPD/PD
(score)
Control 0.44 ± 0.19 255.36 ± 240.31 0.00 ± 0.00 0.81 ± 0.90 1.72 ± 0.45
Peri-implantitis 0.61 ± 0.23 1514.49 ± 888.01 6.00 ± 0.00 5.04 ± 1.81 5.72 ± 0.88
Periodontitis 0.55 ± 0.39 421.79 ± 266.93 5.30 ± 1.11 5.08 ± 0.79 6.34 ± 1.52
PICF/GCF – peri-implant crevicular fluid/gingival crevicular fluid; RANK – receptor activator of nuclear factor kappa-B;
BOP – bleeding on probing; PI – plaque accumulation index; PPD/PD – peri-implant pocket depth/pocket depth
Table 2
Correlation of gender and age with the measured parameters
Patients PICF/GCF
(uL)
RANK
(pg/ml)
BOP
(score)
PI
(score)
PPD/PD
(score)
Gender (M/F) R = -0.049
(p = 0.742)
R = -0.041
(p = 0.786)
R = -0.037
(p = 0.807)
R = 0.015
(p = 0.922)
R = 0,22889
(p = 0,1217)
Age (years) R = -0.024
(p = 0.631)
R = -0.014
(p = 0.802)
R = -0.042
(p = 0.112)
R = 0.045
(p = 0.622)
R = 0,117
(p = 0,1217)
PICF/GCF – peri-implant crevicular fluid/gingival crevicular fluid; RANK – receptor activator of nuclear factor kappa-B;
BOP – bleeding on probing; PI – plaque accumulation index; PPD/PD –peri-implant pocket depth/pocket depth; M – male; F – female
Table 3
Analysis of the differences of clinical and biochemical parameters between the groups (Wilcoxon test)
Groups of patients RANK
(pg/mL)
BOP
(score)
PI
(score)
PPD/PD
(score)
The peri-implantits (P-I) vs control (C) p < 0.0001
P-I > C
p < 0.0001
P-I > C
p = 0.033
P-I > C
p < 0.0001
P-I > C
The peri-implantitis (P-I) vs periodontitis (P-D) p < 0.0001
P-I > P-D p = 0.061 p = 0.109 p = 0.177
The periodontitis (P-D) vs control (C) p = 0.061 p < 0.0001
P-D > C
p < 0.0001
P-D > C
p < 0.0001
P-D > C
RANK – receptor activator of nuclear factor kappa-B; BOP – bleeding on probing; PI – plaque accumulation index;
PPD/PD – peri-implant pocket depth/pocket depth
Table 4
Clinical parameters analysis in implant sites according to RANK concentration
Clinical parameters RANK
< 1,000 pg/mL
RANK
> 1,000 pg/mL
p
PPD (mm) 5.78 ± 1.02 3.57 ± 0.52 < 0001
BOP (score) 6.00 ± 0.00 3.73 ±  0.27 < .0001
PI (score) 5.12 ± 0.42 4.98 ±  0.40 = 0.419
RANK – receptor activator of nuclear factor kappa-B; PPD –peri-implant pocket depth;
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reliable determinant and disease predictor are far from a usable
parameter. To authors’ knowledge this is the first study inves-
tigating RANK in patients suffering from peri-implantitis,
hence direct comparison was limited. In this study, RANK
values were assessed as a potential parameter, peri-implantitis
for concerning its key role as a receptor mediated bone loss.
The mean RANK concetrations were several times
higher in the PICF/GCF samples of peri-implantitis group
comparing to the control group of patients with healthy im-
plants, that had no signs of gingival inflammation. The high-
est individual concentration in healthy implants was lower
than the lowest one in the peri-implantitis, indicating clear
association of high RANK concentrations with peri-implant
inflammation. Furthermore, the significant difference in
RANK concentration was evidenced between the peri-
implantitis and the periodontitis group, with highest levels in
the peri-implantitis group.
From these findings, it could be concluded that a locally
increased RANK concentration provided a potential base for
more intensive inflammation comparing to periodontitis 
28–35.
Our results additionally confirmed the association of
clinical parameters as indicators of inflammation (probing
depths and BOP) with high RANK values.
RANK is known to activate a cascade of intracellular
signaling pathways resulting in rapid nuclear translocation and
transcription of the genes coding pro-inflammatory cytoki-
nes 
35. The process is based on recruitment of TNF receptor-
associated factor (TRAF) proteins that regulate transduction of
signals from RANK with consequential activation of NF-țB as
well as activation of mitogen-activated protein kinase path-
way, where these two are recognized as crucial in regulation of
expression and transcription of the genes coding pro-
inflammatory cytokines. Moreover, RANK poses specific
biological feature to induce osteoclastogenesis ligand inde-
pendently by self-assembling reported by Kanazawa and
Kudo 
29, and additionally supported by Otero et al. 
30. They re-
ported spontaneous osteoclastogenesis based on RANK acti-
vation that was driven by IkB kinase ȕ (IKKȕ) activated by
proinflammatory cytokines TNFĮ and IL-1. In regard to these
facts, increase in RANK could proportionally augment osteo-
clastogenesis independently of his ligand, usually considered
as the main factor in inflammatory bone loss, therewith could
present a pathologic pattern of enhanced inflammatory re-
sponse specific to peri-implant inflammation
 36–38.
Scores of clinical parameters were in general signifi-
cantly higher in inflamed sites as expected considering group
characteristics, but it was observed that the lowest value of
PI in the peri-implantitis group was higher than the highest
value in the healthy implants, and findings of increased PI
are in correspondence with the previous findings of Duarte et
al. 
24. By considering dental plaque as a possible source of of
LPS 
31, 32 increased PI values in peri-implantitis could sug-
gest increase in RANKL expression in response to LPS
stimulation described by Choi et al. 
37. Moreover the asso-
ciation of increased concentration of RANKL with peri-
implantitis and their severity is already reported 
24. Local
osteoclastogenesis could be also enhanced by augmentation
of RANK/RANKL complexes, which are directly propor-
tional to concentration of ligand and receptors found to be
increased in peri-implantitis.
Regarding two proposed mechanisms, RANK increase
could be a powerful enhancer of peri-implant inflammation
by increasing transcriptions of genes coding pro-
inflammatory mediators (such as IL-1, IL-2, IL-6, IL-8, IL-
12, TNFĮ, cyclooxygenase-2 and nitric oxid synthase) 
36 with
consequential elevation of entire cytokine concentration. Lo-
cal cytokine increment induced by locally produced and ex-
pressed RANK could result in osteoclasts differentiation and
upregulation of their activity, the same as under increased
RANKL expression 
17, implicating that RANK could create a
vicious circle with its increase.
On the other side, as documented in experimental models
and in human samples of patients with periodontitis, activated
local CD4 T lymphocytes are principal regulatory cells in al-
veolar bone destruction. In periodontal disease, gingival pro-
duction of inflammatory mediators is under strong influence of
locally activated Th-17 and Th-1 lymphocytes. Furthermore,
Takahashi et al. 
38 anticipated that locally activated IL-17 pro-
ducing T-lymphocytes may be a primary source of RANKL in
perodontitis. If we consider that peri-implantits and periodon-
tits could be generated by similar mechanisms, increased
RANK levels could have intense influence upon local T-
lymphocytes, upregulating their functions, and vice versa, re-
sulting in high osteoclasting activity and bone destruction.
This is the first study suggesting that an increased con-
centration of RANK could be related to peri-implantitis;
thereby the special emphasis of forthcoming researches
should be on the RANK biology, since the numerous studies
were focused on RANKL and OPG 
33, 34.
Conclusion
Taking into consideration the obtained results, increased
concentration of RANK could be a parameter useful for diag-
nosis and monitoring peri-implantitis. On the other side, dis-
solving RANK functioning could provide new therapeutic
strategies by bringing new target for therapeutic acting.
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